REZTRI AEROSPHERE 160/7.2/5 MICROGRAMS/ACTUATION, PRESSURISED INHALATION, SUSPENSION

REZTRI AEROSPHERE 160/7.2/5 MICROGRAMS/ACTUATION, PRESSURISED INHALATION, SUSPENSION

Category: Drug Info

Specifications
Details

Manufacturer
ASTRAZENECA DUNKERQUE PRODUCTION (AZDP)(FRANCE)

Registraction Number
MAL24096022AZ

Content:
  • Budesonide: 160 mcg per actuation
  • Glycopyrronium: 7.2 mcg per actuation
  • Formoterol Fumarate Dihydrate: 5 mcg per actuation
Indications:
  • Maintenance Treatment: Prevents exacerbations and relieves symptoms in adults with moderate, severe, or very severe COPD who require treatment with a combination of an inhaled corticosteroid (ICS), a long-acting beta2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA).
Instructions:
  1. Administration: Inhaled through the mouth using the inhaler device.
  2. Dosage: The recommended dose is 2 puffs (actuations) twice a day (morning and evening).
  3. Timing: Take it at the same time each day to help you remember.
  4. Monitoring: Regular monitoring by your healthcare provider to ensure the medication is effective and to adjust the dose if necessary.

View more about REZTRI AEROSPHERE 160/7.2/5 MICROGRAMS/ACTUATION, PRESSURISED INHALATION, SUSPENSION on main site